Week 48 (Day 338) data from 28 patients in Expansion Cohorts A&B were evaluated with the Phase 3 key secondary endpoint of MDRI and showed a total net response of +2.0 (p-value < 0.0001). The data ...
(See BOOT stock forecast) Next on the list is Summit Therapeutics, a clinical-stage biopharma company that has brought a ...
Reviva is a late-stage biopharmaceutical company that discovers, develops, and seeks to commercialize next-generation therapeutics for diseases representing unmet medical needs and burdens to society, ...
Goldman Sachs has upgraded BioNTech SE (NASDAQ:BNTX), citing the company’s BNT327, an immuno-oncology asset in clinical ...
He also highlighted the success of the Shanghai Cooperation Organization (SCO) summit in Islamabad as a boost to Pakistan’s ...
CENTRAL GOVERNMENT FUNDS: Social welfare would account for the largest portion of the NT$3.33 trillion budget, followed by spending on education, tech and culture ...
An Afghan delegation will attend the upcoming UN climate change summit in Azerbaijan, the foreign ministry spokesman told AFP on Saturday, marking a first since the Taliban government came to power.